Gabrielle C. Geddes1,2, Erin Syverson1,2, Michael G. Earing1,2
Congenital Heart Disease, Vol.14, No.5, pp. 832-837, 2019, DOI:10.1111/chd.12817
Abstract Objective: To describe the first 3 years of experience of having an inpatient “cardiogenetics” program which involves medical geneticist assessment of infants with
major congenital heart disease (CHD) requiring surgical intervention in the first year
of life.
Patients: Patients less than a year of age admitted to Children’s Hospital of Wisconsin’s
Herma Heart Institute for surgical intervention for CHD seen by the cardiogenetics
program. Patients with major trisomies (13, 18, and 21) were excluded.
Outcome Measures: Utilization and yield of genetic testing, and diagnostic rate were
assessed as outcome measures and compared to a baseline time period and… More >